Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation - Full Text View

Purpose

This study seeks to compare patients with vasomotor rhinitis ("perennial nonallergic rhinitis," "idiopathic rhinitis") with normal controls with respect to their nasal physiologic reactivity to cold air challenge. Ten vasomotor rhinitis (VMR) patients with nasal symptoms triggered predominantly by cold air, four VMR patients with symptoms triggered predominantly by chemicals, and ten nonallergic, non-rhinitic control subjects will be studied.

Condition	Intervention
Vasomotor Rhinitis	Other: Cold-dry air provocation Other: Warm-moist air provocation


Study Type:	Interventional
Study Design:	Allocation: Randomized Intervention Model: Crossover Assignment Masking: Investigator Primary Purpose: Diagnostic
Official Title:	Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation

Further study details as provided by Stephen A. Tilles MD, Associated Scientists to Help Minimize Allergies:

Primary Outcome Measures:

Net Proportional Change in Nasal Airway Resistance [ Time Frame: One hour ]
Net proportional change in nasal airway resistance, pre- to post-exposure, cold air minus warm air day, calculated as a time-weighted average over the 1.0 h post-exposure. At each time point (pre-exposure, immediately post-exposure, and at 15-, 30-, 45- and 60 minutes post-exposure), nasal airway resistance (in Pa/L/sec) was measured in triplicate. The average of each of these measures was taken for each time point. The time-weighted average of these averages was then calculated for the post-exposure time points and compared with the baseline average for that individual on that testing day. The proportional change from baseline on that day was then calculated (unit-less measure). The difference between the pre-to-post change on the cold air day minus the pre-to-post change on the warm air day was then calculated (unit-less measure). The net proportional change corrects for both inter- and intra-individual variability, which in the case of nasal airway resistance is considerable.


Enrollment:	24
Study Start Date:	December 2006
Study Completion Date:	May 2008
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Order 1 Cold-dry air provocation followed (on a separate day) by Warm-moist air provocation	Other: Cold-dry air provocation 15 minute exposure to cold-dry air by nasal mask Other: Warm-moist air provocation 15 minute exposure to warm-moist air by nasal mask
Experimental: Order 2 Warm-moist air provocation followed (on a separate day) by Cold-dry air provocation	Other: Cold-dry air provocation 15 minute exposure to cold-dry air by nasal mask Other: Warm-moist air provocation 15 minute exposure to warm-moist air by nasal mask

Detailed Description:

After initial screening and verification that subjects can cooperate with active posterior rhinomanometry, subjects will be scheduled for two 15-minute exposure sessions with either: cold-dry air, or warm-moist air. Subjects will rate symptoms (and have their nasal airway resistance measured in triplicate) prior to exposure and at 15-min. intervals post-exposure until an hour has passed.

Eligibility


Ages Eligible for Study:	18 Years to 60 Years (Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

(cases; n = 14 total; 10 with predominantly "physical" and 4 with predominantly "irritant"triggers):

A significant history of chronic and/or recurrent nasal symptoms (rhinorrhea, blockage,sneezing or pruritus) in response to:
1. Changes in temperature and/or humidity predominantly ("physical triggers"; n = 10); or
2. Two or more nonspecific irritant triggers predominantly, including: perfumes or colognes,cleaning products, environmental tobacco smoke, vehicular exhaust, paint odors, etc. ("irritant triggers";n = 4). This history shall be of at least two years' duration.

Exclusion Criteria:

(controls; n = 10):

A significant history of chronic and/or recurrent nasal symptoms (rhinorrhea, blockage,sneezing or pruritus) in response to one or more nonallergic triggers, including: perfumes or colognes, cleaning products, environmental tobacco smoke, vehicular exhaust, paint odors, changes in temperature and/or humidity.

Exclusion criteria:

(all subjects; n = 24):

A prior history of allergic disease (allergic rhinitis, asthma, angioedema, anaphylaxis)
Significant skin test reactivity to one or more substances in a panel of 24 locally relevant seasonal and perennial aeroallergens
Negative wheal response to positive control (histamine) on skin test panel
Abnormalities on a screening x-ray (Waters view) of the paranasal sinuses
Cigarette smoking (active, within previous 6 months or cumulative history of >20 pack years)
Chronic cardiopulmonary diseases (asthma, COPD, coronary artery disease…)
Continuous therapy with medications having antihistaminic or autonomic primary or secondary effects (e.g., oral or topical antihistamines, tricyclic antidepressants, ipratropium bromide, albuterol, alpha- or beta-adrenergic blockers...)
Unable to provide meaningful tracings on screening rhinomanometry.
Pregnancy (or planned pregnancy within 6 months); positive urinary HCG at screening visit. Patient is a breast feeding female.
Upper respiratory infection (common cold or sinusitis) within 2 week of screening.
Patient has participated in a clinical trial involving an investigational drug within 4 weeks of visit 1.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00415493

Locations


United States, Washington
ASTHMA, Inc.
Seattle, Washington, United States, 98105

Sponsors and Collaborators

Associated Scientists to Help Minimize Allergies

University of Washington

Investigators


Principal Investigator:	Dennis Shusterman, MD, MPH	University of Washington
Study Director:	Stephen A Tilles,, MD	ASTHMA, Inc.

More Information

Additional Information:

Clinical Research Facility This link exits the ClinicalTrials.gov site


Responsible Party:	Stephen A. Tilles MD, Executive Director, Associated Scientists to Help Minimize Allergies
ClinicalTrials.gov Identifier:	NCT00415493 History of Changes
Other Study ID Numbers:	AI-005 NAR
Study First Received:	December 21, 2006
Results First Received:	July 20, 2012
Last Updated:	January 23, 2017
Individual Participant Data
Plan to Share IPD:	No

Keywords provided by Stephen A. Tilles MD, Associated Scientists to Help Minimize Allergies:


rhinitis non-allergic rhinitis rhinomanometry cold air	triggers: cold, dry air inhalation warm, most air inhalation Nonallergic rhinitis; normal controls

Additional relevant MeSH terms:


Rhinitis Rhinitis, Vasomotor Nose Diseases	Respiratory Tract Diseases Respiratory Tract Infections Otorhinolaryngologic Diseases

ClinicalTrials.gov processed this record on June 26, 2017